Fri, Feb 27, 2015, 9:10 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Exact Sciences Corporation Message Board

  • crapnebula crapnebula Jul 2, 2013 9:21 AM Flag

    What they said in Barons:

    "Exact Sciences is risky. It has minimal revenue and is betting its future on the colon-cancer test. If trial results are disappointing and the test doesn't clear the FDA, the shares might collapse."
    The stock was at 9.80 at the time. The words ring as true as ever at 14.44

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Barron's also said the stock would be $20s by next year.

      Sentiment: Strong Buy

    • Wow you useless welfare #$%$ just don't give up eh? Trial results have been in for awhile and your still bashing with old news?? Your bosses can't be happy with your pitiful lousy bashing performance, looks like your gonna be under his desk sucking for your job and swallowing everything he gives ya!!! Then you still gotta go home to your parents basement and live with the roaches.....back to the gay bars for you turning tricks to make ends meet.....

    • Trial results were great! And by far good enough for FDA


      • 1 Reply to mstevens19600
      • What, are you claiming to work for the FDA now? Lol. The FDA has said NOTHING of the sort. In fact when the trial results were out, the manipulators were unable to prop the stock up and the ensuing FLOOD of sell orders took the stock momentarily down into the high 6's. Even this was a bargain for me and I bought in the low 7s that morning. I have since unloaded. The precancer detection results while not abysmal WERE terribly disappointing to many of us. You had better be careful if you believe you are on solid footing up here in the nosebleed seats. 14 wont hold and you know it.

        Sentiment: Sell

22.47-0.89(-3.81%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Opko Health, Inc.
NYSEFri, Feb 27, 2015 4:01 PM EST
Herbalife Ltd.
NYSEFri, Feb 27, 2015 4:01 PM EST